Roundup Cancer

What the lawsuit is about

Lawsuits allege that glyphosate-based Roundup exposure may be associated with non-Hodgkin lymphoma and that warnings were inadequate.

Claims may involve Roundup and glyphosate-based herbicide products. Plaintiffs claim they experienced injuries after use or exposure, while defendants generally dispute allegations, causation, liability, or damages. No page on this site can determine whether a person qualifies for a claim.

Roundup Cancer Lawsuit Update: May 2026

Roundup cancer litigation remains active, but it is a mature litigation with a long history of federal MDL proceedings, state court cases, appeals, and settlement activity. Federal Roundup product liability cases have been coordinated in MDL No. 2741 in the Northern District of California, while many claims have also proceeded through state courts or settlement-related processes.

As of May 2026, Roundup appears more settlement-focused than newer mass torts, but public settlement activity does not mean every claim is resolved or that a person automatically qualifies. Current legal issues include proposed settlement procedures, objections or disputes over settlement structure, federal preemption arguments, warning-law questions, and how prior releases or opt-out decisions affect individual rights.

Recent public news has focused on a proposed multibillion-dollar settlement and legal disputes that could affect timing, approval, or participation. For people researching the case, the important takeaway is to identify product-use history, diagnosis details, and any prior claim paperwork before assuming a new or additional legal option exists.

Case Status Snapshot

• Status: Active / Settlement-focused
• Primary injury: Non-Hodgkin lymphoma
• Main product/exposure: Roundup and other glyphosate-based herbicide products
• MDL or court context: MDL No. 2741, Northern District of California, with related state court and settlement activity
• Settlement status: Public proposed settlement activity exists, but approval, eligibility, timing, and individual outcomes remain fact-specific
• Key deadline: Varies by state, diagnosis date, exposure history, discovery facts, prior settlement participation, and court orders
• State law relevance: State law may affect warnings claims, damages, limitations periods, release issues, and wrongful death claims

Litigation Updates and Timeline

• 2016: Federal Roundup cases were centralized in MDL No. 2741 in the Northern District of California for coordinated pretrial proceedings.
• 2018-2020: Early trials, appeals, and settlement discussions shaped the national litigation and brought broader attention to glyphosate-related non-Hodgkin lymphoma claims.
• 2020-2025: Many claims moved through settlement programs, state court proceedings, appeals, and continuing disputes over warnings and causation.
• February 2026: Public reports described a proposed multibillion-dollar Roundup settlement intended to address large groups of current and future claims, subject to court process and objections.
• May 2026: Public reports described legal disputes that could affect settlement timing, approval, deadlines, or the forum handling settlement-related issues.

Current litigation status

Roundup cancer claims remain active, although the litigation is more mature than some newer mass torts. Federal Roundup product liability cases have long been coordinated in MDL No. 2741 in the Northern District of California, and many claims have also proceeded in state courts or settlement programs.

The litigation involves allegations that exposure to Roundup or other glyphosate-based herbicides is associated with non-Hodgkin lymphoma and that warnings were inadequate. Defendants dispute causation, warning, liability, and damages issues. Because Roundup litigation includes federal proceedings, state court trials, appeals, settlement activity, and ongoing legal disputes, status can change quickly. This guide is a general overview rather than a live docket report.

Key issues in the lawsuit

Roundup lawsuits generally focus on whether repeated exposure to glyphosate-based herbicides can be linked to non-Hodgkin lymphoma and whether Monsanto or related defendants adequately warned users about alleged cancer risks. Plaintiffs may include agricultural workers, landscapers, groundskeepers, homeowners, nursery workers, parks employees, school or municipal workers, and others who used or handled Roundup repeatedly.

The key factual issues include how often the person used Roundup, whether exposure was occupational or residential, whether the person mixed concentrate or used ready-to-use products, what protective equipment was used, and whether the diagnosis is a type of non-Hodgkin lymphoma being evaluated. Legal issues may include warning adequacy, causation, federal preemption arguments, state-law deadlines, settlement releases, and proof of damages.

Defendants may argue that regulatory labeling was adequate, that scientific evidence does not prove causation for a particular person, that exposure was too limited, or that other risk factors explain the cancer. Plaintiffs may point to repeated use, product history, diagnosis records, and expert causation evidence.

Roundup claims can also turn on the difference between casual product use and repeated exposure. A homeowner who sprayed weeds once or twice may present a different review than a worker who mixed concentrate, sprayed large areas, cleaned equipment, or handled the product as part of routine job duties over many seasons.

How claims may be evaluated

A Roundup claim review usually begins with exposure history. Relevant records may include purchase receipts, employment records, landscaping or groundskeeping job descriptions, farm records, pesticide application logs, photographs of product containers, invoices, property maintenance records, and witness statements. The review may look at how many years the person used Roundup, how often it was applied, whether concentrate was mixed, and whether exposure involved skin contact, inhalation, spills, or overspray.

Medical records are equally important. Oncology records, pathology reports, biopsy records, chemotherapy records, radiation records, transplant records, recurrence history, and records identifying the type of non-Hodgkin lymphoma may be needed. A lawyer may also ask about diagnosis date, symptoms, treatment course, remission, recurrence, and long-term effects.

Causation review may consider latency, duration of exposure, intensity of exposure, other pesticide or chemical exposure, family history, immune conditions, age, prior cancers, and other medical risk factors. A strong claim review usually depends on both documented exposure and confirmed diagnosis.

Common fact patterns

One common fact pattern may involve a groundskeeper, landscaper, farmer, or maintenance worker who used Roundup regularly for years and later developed non-Hodgkin lymphoma. Another may involve a homeowner or property owner who used Roundup repeatedly around driveways, fence lines, gardens, fields, or large properties over an extended period.

Some people may have direct purchase records or photographs showing the products they used. Others may rely on employment records, co-worker statements, maintenance logs, or testimony about routine use. A claim may be easier to evaluate when the person can identify the product, approximate years of use, frequency of application, whether concentrate was mixed, and the diagnosis subtype.

For workplace histories, job titles alone may not tell the full story. A school employee, municipal worker, landscaper, farmhand, or groundskeeper may need to describe the actual tasks performed, who supplied the product, whether safety equipment was available, and whether application happened seasonally or year-round.

Roundup claims may also involve people who have already participated in a settlement program or received prior claim paperwork. In those situations, any release, settlement agreement, or claim form should be reviewed before assuming another legal option exists.

What can make a claim harder to evaluate

Roundup claims can be harder when exposure is occasional, poorly documented, or limited to a short period. Vague memories of weed killer use may not be enough if the person cannot identify Roundup or another glyphosate-based product. Missing purchase records, uncertain job duties, or lack of witnesses can also complicate exposure proof.

Medical factors may also affect review. Non-Hodgkin lymphoma includes multiple subtypes, and some diagnoses may be evaluated differently than others. Prior cancer history, immune disorders, family history, other chemical exposures, or incomplete pathology records may require closer review.

Legal issues can be significant in Roundup cases because the litigation has been active for years. Prior settlements, releases, opt-out decisions, appeal issues, or expired state deadlines may affect whether a new or additional claim can be pursued. These questions require individualized legal advice.

Why state law may still matter

Roundup litigation has involved both federal coordination and state court proceedings, so state law can be especially important. The state where exposure occurred, the state where the person lived or worked, and the state where a case is filed can affect deadlines, warning-law arguments, damages, evidence rules, and wrongful death claims.

State discovery rules may affect when a deadline begins to run, particularly if a person was diagnosed years before learning about possible litigation. State law may also affect whether prior settlement paperwork or releases limit additional claims. National litigation history does not replace state-specific legal analysis.

Questions to ask before contacting a lawyer

• Can I identify the Roundup or glyphosate product I used?
• Was my exposure occupational, residential, agricultural, or landscaping-related?
• How often did I apply the product, and for how many years?
• What type of non-Hodgkin lymphoma was diagnosed, and when?
• Have I signed any settlement, release, or claim paperwork before?
• Which state’s deadline rules may apply to my exposure and diagnosis timeline?

Sources and status notes

• Federal court context: Federal Roundup product liability cases have been coordinated in MDL No. 2741 in the Northern District of California, with related state-court and settlement activity.
• Agency or medical context: Public context may involve glyphosate regulatory materials, product-labeling issues, and court materials addressing warnings, causation, settlement, and appeal issues. EPA maintains public information on glyphosate.
• Litigation status: This guide summarizes public litigation status information and should not be treated as a live court docket. Roundup litigation is mature and settlement-focused compared with newer mass torts, but individual claim status remains fact-specific.
• Review note: Case status, settlement posture, deadlines, and eligibility factors can change.
• Last reviewed: May 23, 2026.

Who may be affected

• People with documented use of or exposure to Roundup and glyphosate-based herbicide products.
• People later diagnosed with non-Hodgkin lymphoma.
• People who can identify approximate dates, locations, providers, employers, or exposure circumstances.
• Families evaluating possible wrongful death issues should ask a lawyer how state law may apply.

Injuries involved

• Non-Hodgkin lymphoma
• Glyphosate exposure
• Agricultural exposure
• Landscaping or groundskeeping exposure

Evidence usually needed

• Product use history
• Employment or groundskeeping records
• Purchase records
• Medical diagnosis records
• Oncology records
• Treatment records

Timeline

Settlement status

Roundup litigation is more mature and more settlement-focused than many newer mass torts, but that does not mean every claim is resolved or that any person has a guaranteed recovery. Public reports in 2026 described proposed settlement activity and legal disputes over how a broader settlement might proceed. Individual options may depend on diagnosis type, exposure history, prior settlement paperwork, opt-out or release issues, state deadlines, and ongoing court or appellate rulings.

Deadline overview

Deadlines vary by state and may depend on diagnosis date, discovery date, exposure history, wrongful death issues, and other facts. A lawyer can evaluate how the relevant deadline rules may apply.

State-by-state guide links